-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
MoonLake Immunotherapeutics quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2021 to Q3 2025.
- MoonLake Immunotherapeutics Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $3.71M, a 101% increase year-over-year.
- MoonLake Immunotherapeutics Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $11.2M, a 61.7% increase year-over-year.
- MoonLake Immunotherapeutics annual Share-based Payment Arrangement, Expense for 2024 was $7.28M, a 2.47% increase from 2023.
- MoonLake Immunotherapeutics annual Share-based Payment Arrangement, Expense for 2023 was $7.11M, a 26.4% decline from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)